Cargando…

Adipose-derived mesenchymal stem cells rescue rat hippocampal cells from aluminum oxide nanoparticle-induced apoptosis via regulation of P53, Aβ, SOX2, OCT4, and CYP2E1

Mesenchymal stem cells (MSCs) possess a preventive capacity against free radical toxicity in various tissues. The present study aimed to demonstrate the reformative and treatment roles of adipose-derived MSCs (AD-MSCs) against severe toxicity in the hippocampal cells of the brain caused by aluminum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Atia, Mona M., Alghriany, Alshaimaa A.I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190131/ https://www.ncbi.nlm.nih.gov/pubmed/34150525 http://dx.doi.org/10.1016/j.toxrep.2021.06.003

Ejemplares similares

Assessment of the Toxicity of Aluminum Oxide and Its Nanoparticles in the Bone Marrow and Liver of Male Mice: Ameliorative Efficacy of Curcumin Nanoparticles
por: Alghriany, Alshaimaa A. I., et al.
Publicado: (2022)

Enhanced proliferation and differentiation of Oct4- and Sox2-overexpressing human adipose tissue mesenchymal stem cells
por: Han, Sei-Myoung, et al.
Publicado: (2014)

Enhanced Hepatogenic Transdifferentiation of Human Adipose Tissue Mesenchymal Stem Cells by Gene Engineering with Oct4 and Sox2
por: Han, Sei-Myoung, et al.
Publicado: (2015)

Differential Expression of ID4 and Its Association with TP53 Mutation, SOX2, SOX4 and OCT-4 Expression Levels
por: Galatro, Thais Fernanda de Almeida, et al.
Publicado: (2013)

Correction: Enhanced Hepatogenic Transdifferentiation of Human Adipose Tissue Mesenchymal Stem Cells by Gene Engineering with Oct4 and Sox2
por: Han, Sei-Myoung, et al.
Publicado: (2017)

Immunoexpression of stem cell markers SOX-2, NANOG AND OCT4 in ameloblastoma
por: Martins Balbinot, Karolyny, et al.
Publicado: (2023)

Gallic acid rescues uranyl acetate induced-hepatic dysfunction in rats by its antioxidant and cytoprotective potentials
por: Elmileegy, Ibtisam M. H., et al.
Publicado: (2023)

Prognostic significance of Oct4 and Sox2 expression in hypopharyngeal squamous cell carcinoma
por: Ge, Nan, et al.
Publicado: (2010)

The dyskerin ribonucleoprotein complex as an OCT4/SOX2 coactivator in embryonic stem cells
por: Fong, Yick W, et al.
Publicado: (2014)

Endogenous fluctuations of OCT4 and SOX2 bias pluripotent cell fate decisions
por: Strebinger, Daniel, et al.
Publicado: (2019)

Characterization of SOX2, OCT4 and NANOG in Ovarian Cancer Tumor-Initiating Cells
por: Robinson, Mikella, et al.
Publicado: (2021)

Elevating the levels of Sox2 in embryonal carcinoma cells and embryonic stem cells inhibits the expression of Sox2:Oct-3/4 target genes(†)
por: Boer, Brian, et al.
Publicado: (2007)

Expression of SOX2 and OCT4 in odontogenic cysts and tumors
por: Phattarataratip, Ekarat, et al.
Publicado: (2021)

Heterogeneity in Oct4 and Sox2 Targets Biases Cell Fate in 4-Cell Mouse Embryos
por: Goolam, Mubeen, et al.
Publicado: (2016)

Regulation of tumorigenesis in oral epithelial cells by defined reprogramming factors Oct4 and Sox2
por: Cai, Jinghua, et al.
Publicado: (2016)

Exogenous OCT4 and SOX2 Contribution to In Vitro Reprogramming in Cattle
por: Machado, Lucas Simões, et al.
Publicado: (2023)

Interplay of Oct4 with Sox2 and Sox17: a molecular switch from stem cell pluripotency to specifying a cardiac fate
por: Stefanovic, Sonia, et al.
Publicado: (2009)

Expression of Sox2 and Oct4 and Their Clinical Significance in Human Non-Small-Cell Lung Cancer
por: Li, Xinxin, et al.
Publicado: (2012)

Effect of overexpression of Oct4 and Sox2 genes on the biological and oncological characteristics of gastric cancer cells
por: Chen, Borong, et al.
Publicado: (2019)

SOX2, OCT4 and NANOG: The core embryonic stem cell pluripotency regulators in oral carcinogenesis
por: Swain, Niharika, et al.
Publicado: (2020)

Dissecting the role of distinct OCT4-SOX2 heterodimer configurations in pluripotency
por: Tapia, Natalia, et al.
Publicado: (2015)

Clinical significance of OCT4 and SOX2 protein expression in cervical cancer
por: Kim, Bo Wook, et al.
Publicado: (2015)

Differential Nucleosome Occupancies across Oct4-Sox2 Binding Sites in Murine Embryonic Stem Cells
por: Sebeson, Amy, et al.
Publicado: (2015)

Prognostic Significance of the Pluripotency Factors NANOG, SOX2, and OCT4 in Head and Neck Squamous Cell Carcinomas
por: Pedregal-Mallo, Daniel, et al.
Publicado: (2020)

Bufalin attenuates triple-negative breast cancer cell stemness by inhibiting the expression of SOX2/OCT4
por: Chen, Fei, et al.
Publicado: (2020)

Mutations in TP53 increase the risk of SOX2 copy number alterations and silencing of TP53 reduces SOX2 expression in non-small cell lung cancer
por: Samulin Erdem, Johanna, et al.
Publicado: (2016)

Enhanced OCT4 transcriptional activity substitutes for exogenous SOX2 in cellular reprogramming
por: Marthaler, Adele G., et al.
Publicado: (2016)

Negative reciprocity, not ordered assembly, underlies the interaction of Sox2 and Oct4 on DNA
por: Biddle, John W, et al.
Publicado: (2019)

Expression of early transcription factors Oct-4, Sox-2 and Nanog by porcine umbilical cord (PUC) matrix cells
por: Carlin, Ryan, et al.
Publicado: (2006)

Geminin Escapes Degradation in G1 of Mouse Pluripotent Cells and Mediates the Expression of Oct4, Sox2, and Nanog
por: Yang, Valerie S., et al.
Publicado: (2011)

Human Ocular Epithelial Cells Endogenously Expressing SOX2 and OCT4 Yield High Efficiency of Pluripotency Reprogramming
por: Poon, Ming-Wai, et al.
Publicado: (2015)

XPC Promotes Pluripotency of Human Dental Pulp Cells through Regulation of Oct-4/Sox2/c-Myc
por: Liu, Lu, et al.
Publicado: (2016)

Effect of Luteolin and Apigenin on the Expression of Oct-4, Sox2, and c-Myc in Dental Pulp Cells with In Vitro Culture
por: Liu, Lu, et al.
Publicado: (2015)

Phosphorylation of Threonine(343) Is Crucial for OCT4 Interaction with SOX2 in the Maintenance of Mouse Embryonic Stem Cell Pluripotency
por: Abulaiti, Xianmixinuer, et al.
Publicado: (2017)

Expression of OCT-4 and SOX-2 in Bone Marrow-Derived Human Mesenchymal Stem Cells during Osteogenic Differentiation
por: Matic, Igor, et al.
Publicado: (2016)

Dynamical reorganization of the pluripotency transcription factors Oct4 and Sox2 during early differentiation of embryonic stem cells
por: Verneri, Paula, et al.
Publicado: (2020)

DDX53 Regulates Cancer Stem Cell-Like Properties by Binding to SOX-2
por: Kim, Youngmi, et al.
Publicado: (2017)

Pluripotency of periodontal ligament and dental pulp cells is induced by intercellular communication via the CDX2/Oct-4/Sox2 pathway
por: Wei, Yaru, et al.
Publicado: (2022)

Deciphering the Sox-Oct partner code by quantitative cooperativity measurements
por: Ng, Calista K. L., et al.
Publicado: (2012)

Heterokaryon-Based Reprogramming of Human B Lymphocytes for Pluripotency Requires Oct4 but Not Sox2
por: Pereira, Carlos F., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_csmavrteg34qop0h20jknbv0kq